NeoGenomics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (29)

View All

Latest Posts

About This Stock More About This Stock
NeoGenomics Stock Surged But Technicals Point To A Pullback
Article By: Invezz
Thursday, February 22, 2024 1:25 AM EDT
NeoGenomics stock price popped sharply this week after the company published strong financial results. It soared to a high of $16.50, its highest point since December 29th. It has soared by more than 20% from its lowest point this week.
In this article: NEO
Read
Bull Of The Day - NeoGenomics
Article By: Kevin Cook
Friday, January 12, 2024 9:37 AM EDT
But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context.
In this article: NEO Also: NTRA, GH
Read
Bull Of The Day: NeoGenomics
Article By: Kevin Cook
Tuesday, October 24, 2023 11:40 AM EDT
NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer.
In this article: NEO Also: NTRA, GH
Read
5 Toxic Stocks To Abandon Or Play Short For Profit
Article By: Zacks Investment Research
Friday, July 21, 2017 2:17 PM EDT
The success of an investor depends on proper identification of overpriced toxic stocks and the rightly priced ones.
In this article: CRM, CVA, LYV, PAYC, NEO
Read
3 Top Stocks In The Last 72 Hours (And 1 Stock Warning)
Article By: TipRanks
Sunday, May 28, 2017 4:17 PM EDT
We filtered the options to best-rated stocks in the last 72 hours from any sector and with any market cap size. We crunched the data and the results came out as these three ‘strong buy’ stocks: NeoGenomics, Broadcom and Aerie Pharma.
In this article: ANF, AVGO, AERI, NEO
Read
All Posts

Latest Tweets for $NEO

No tweets yet!

PARTNER HEADLINES